The wire › SEC Form 8-K
Arch Therapeutics, Inc.
Filed with the SEC on May 23, 2025. Reported event date Dec 29, 2024.
- Business address
- Framingham, MA
- State
- Massachusetts
- Incorporated in
- Nevada
- Industry
- Manufacturing (SIC 3841)
- SEC CIK
- 1537561
- Accession number
- 0001641172-25-012288
Items reported in this filing
- Item 1.03 Bankruptcy or Receivership
A bankruptcy case or a receivership has started for the company or one of its main subsidiaries: the company itself reports it on Form 8-K Item 1.03.
- Item 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
- Item 4.01 Changes in Registrant's Certifying Accountant
- Item 8.01 Other Events
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing